Liver transplantation in propionic acidaemia

J. M. Saudubray, G. Touati, P. Delonlay, P. Jouvet, J. Schlenzig, C. Narcy, J. Laurent, D. Rabier, P. Kamoun, Dominique M. Jan, Y. Revillon

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Despite the improvement in dietary therapy during the past 20 years, the overall outcome of severe forms of propionic acidaemia (PA) remains often disappointing. Good results can be obtained at a very high price in terms of medical attention, family burden and high cost. In most early onset forms of PA, the intake of natural protein must be rigidly restricted to 8-12 g/day for the first 3 years of life, and then slowly increased to 15-20 g/day by the age of 6-8 years. Supplementation with a precursor-free aminoacid mixture to provide 1.5 g/kg protein per day is generally recommended, although remains controversial. From the age of 1 year onward, these children are often severely anorectic and most of the diet must be delivered by nocturnal gastric drip feeding or gastrostomy. Metronidazole is very effective in reducing the excretion of propionate metabolites derived from the gut. L- carnitine (50 to 100 mg/kg) is systematically given to promote propionylcarnitine synthesis and excretion. We report here a retrospective study of 33 patients with PA diagnosed during the last 20 years in our hospital. Of them, 2 have been liver transplanted. In these two patients who presented frequent severe and unexpected metabolic decompensations despite good compliance with the dietary therapy, orthotopic liver transplantation (OLT) was done at 7 and 9 years respectively. One child died 15 months after transplantation due to a severe lymphoproliferative disorder; the other child now aged 13.5 years is doing well. Despite a persistent methylcitrate excretion, she is under normal moderate daily protein intake (40-50 g/day) and still on carnitine supplementation. Interestingly, another patient who filled the criteria for OLT (very frequent and severe decompensations leading to frequent admissions to the intensive care unit despite excellent dietary management) was also placed on the list for OLT. From the time he was registered onward, he experienced no further episodes of metabolic decompensation, there was almost no interruption in his daily intake and he gained height and weight and developed well. He was finally removed from the list and is still doing very well 2 years thereafter. Correction of propionylCoA carboxylase deficiency restricted to hepatic tissues seems to induce a change towards clinical normalisation and a milder biochemical phenotype. Liver transplanted PA patients still require slight protein restriction and carnitine treatment. We consider that at the moment OLT should only be performed in severe forms of PA, mostly characterised by frequent and unexpected episodes of metabolic decompensation despite good dietary therapy. However, a strict appreciation of these criteria is difficult. A more generalised indication for OLT in PA will require more information about the long-term outcome of transplanted patients. We should also await other alternatives like auxiliary partial OLT from living donors or transplantation of isolated allogenic hepatocytes, genetically modified or not.

Original languageEnglish (US)
JournalEuropean Journal of Pediatrics, Supplement
Volume158
Issue number2
StatePublished - 1999
Externally publishedYes

Fingerprint

Propionic Acidemia
Liver Transplantation
Carnitine
propionylcarnitine
Liver
Proteins
Appetite Depressants
Gastrostomy
Lymphoproliferative Disorders
Living Donors
Homologous Transplantation
Metronidazole
Propionates
Therapeutics
Intensive Care Units
Hepatocytes
Stomach
Retrospective Studies
Transplantation
Diet

Keywords

  • Liver transplantation
  • Management of inborn errors of metabolism
  • Propionic acidaemia
  • PropionylCoA carboxylase

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Saudubray, J. M., Touati, G., Delonlay, P., Jouvet, P., Schlenzig, J., Narcy, C., ... Revillon, Y. (1999). Liver transplantation in propionic acidaemia. European Journal of Pediatrics, Supplement, 158(2).

Liver transplantation in propionic acidaemia. / Saudubray, J. M.; Touati, G.; Delonlay, P.; Jouvet, P.; Schlenzig, J.; Narcy, C.; Laurent, J.; Rabier, D.; Kamoun, P.; Jan, Dominique M.; Revillon, Y.

In: European Journal of Pediatrics, Supplement, Vol. 158, No. 2, 1999.

Research output: Contribution to journalArticle

Saudubray, JM, Touati, G, Delonlay, P, Jouvet, P, Schlenzig, J, Narcy, C, Laurent, J, Rabier, D, Kamoun, P, Jan, DM & Revillon, Y 1999, 'Liver transplantation in propionic acidaemia', European Journal of Pediatrics, Supplement, vol. 158, no. 2.
Saudubray JM, Touati G, Delonlay P, Jouvet P, Schlenzig J, Narcy C et al. Liver transplantation in propionic acidaemia. European Journal of Pediatrics, Supplement. 1999;158(2).
Saudubray, J. M. ; Touati, G. ; Delonlay, P. ; Jouvet, P. ; Schlenzig, J. ; Narcy, C. ; Laurent, J. ; Rabier, D. ; Kamoun, P. ; Jan, Dominique M. ; Revillon, Y. / Liver transplantation in propionic acidaemia. In: European Journal of Pediatrics, Supplement. 1999 ; Vol. 158, No. 2.
@article{53f2ce8c455c48619250ac75c77a3f6b,
title = "Liver transplantation in propionic acidaemia",
abstract = "Despite the improvement in dietary therapy during the past 20 years, the overall outcome of severe forms of propionic acidaemia (PA) remains often disappointing. Good results can be obtained at a very high price in terms of medical attention, family burden and high cost. In most early onset forms of PA, the intake of natural protein must be rigidly restricted to 8-12 g/day for the first 3 years of life, and then slowly increased to 15-20 g/day by the age of 6-8 years. Supplementation with a precursor-free aminoacid mixture to provide 1.5 g/kg protein per day is generally recommended, although remains controversial. From the age of 1 year onward, these children are often severely anorectic and most of the diet must be delivered by nocturnal gastric drip feeding or gastrostomy. Metronidazole is very effective in reducing the excretion of propionate metabolites derived from the gut. L- carnitine (50 to 100 mg/kg) is systematically given to promote propionylcarnitine synthesis and excretion. We report here a retrospective study of 33 patients with PA diagnosed during the last 20 years in our hospital. Of them, 2 have been liver transplanted. In these two patients who presented frequent severe and unexpected metabolic decompensations despite good compliance with the dietary therapy, orthotopic liver transplantation (OLT) was done at 7 and 9 years respectively. One child died 15 months after transplantation due to a severe lymphoproliferative disorder; the other child now aged 13.5 years is doing well. Despite a persistent methylcitrate excretion, she is under normal moderate daily protein intake (40-50 g/day) and still on carnitine supplementation. Interestingly, another patient who filled the criteria for OLT (very frequent and severe decompensations leading to frequent admissions to the intensive care unit despite excellent dietary management) was also placed on the list for OLT. From the time he was registered onward, he experienced no further episodes of metabolic decompensation, there was almost no interruption in his daily intake and he gained height and weight and developed well. He was finally removed from the list and is still doing very well 2 years thereafter. Correction of propionylCoA carboxylase deficiency restricted to hepatic tissues seems to induce a change towards clinical normalisation and a milder biochemical phenotype. Liver transplanted PA patients still require slight protein restriction and carnitine treatment. We consider that at the moment OLT should only be performed in severe forms of PA, mostly characterised by frequent and unexpected episodes of metabolic decompensation despite good dietary therapy. However, a strict appreciation of these criteria is difficult. A more generalised indication for OLT in PA will require more information about the long-term outcome of transplanted patients. We should also await other alternatives like auxiliary partial OLT from living donors or transplantation of isolated allogenic hepatocytes, genetically modified or not.",
keywords = "Liver transplantation, Management of inborn errors of metabolism, Propionic acidaemia, PropionylCoA carboxylase",
author = "Saudubray, {J. M.} and G. Touati and P. Delonlay and P. Jouvet and J. Schlenzig and C. Narcy and J. Laurent and D. Rabier and P. Kamoun and Jan, {Dominique M.} and Y. Revillon",
year = "1999",
language = "English (US)",
volume = "158",
journal = "European Journal of Pediatrics, Supplement",
issn = "0943-9676",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Liver transplantation in propionic acidaemia

AU - Saudubray, J. M.

AU - Touati, G.

AU - Delonlay, P.

AU - Jouvet, P.

AU - Schlenzig, J.

AU - Narcy, C.

AU - Laurent, J.

AU - Rabier, D.

AU - Kamoun, P.

AU - Jan, Dominique M.

AU - Revillon, Y.

PY - 1999

Y1 - 1999

N2 - Despite the improvement in dietary therapy during the past 20 years, the overall outcome of severe forms of propionic acidaemia (PA) remains often disappointing. Good results can be obtained at a very high price in terms of medical attention, family burden and high cost. In most early onset forms of PA, the intake of natural protein must be rigidly restricted to 8-12 g/day for the first 3 years of life, and then slowly increased to 15-20 g/day by the age of 6-8 years. Supplementation with a precursor-free aminoacid mixture to provide 1.5 g/kg protein per day is generally recommended, although remains controversial. From the age of 1 year onward, these children are often severely anorectic and most of the diet must be delivered by nocturnal gastric drip feeding or gastrostomy. Metronidazole is very effective in reducing the excretion of propionate metabolites derived from the gut. L- carnitine (50 to 100 mg/kg) is systematically given to promote propionylcarnitine synthesis and excretion. We report here a retrospective study of 33 patients with PA diagnosed during the last 20 years in our hospital. Of them, 2 have been liver transplanted. In these two patients who presented frequent severe and unexpected metabolic decompensations despite good compliance with the dietary therapy, orthotopic liver transplantation (OLT) was done at 7 and 9 years respectively. One child died 15 months after transplantation due to a severe lymphoproliferative disorder; the other child now aged 13.5 years is doing well. Despite a persistent methylcitrate excretion, she is under normal moderate daily protein intake (40-50 g/day) and still on carnitine supplementation. Interestingly, another patient who filled the criteria for OLT (very frequent and severe decompensations leading to frequent admissions to the intensive care unit despite excellent dietary management) was also placed on the list for OLT. From the time he was registered onward, he experienced no further episodes of metabolic decompensation, there was almost no interruption in his daily intake and he gained height and weight and developed well. He was finally removed from the list and is still doing very well 2 years thereafter. Correction of propionylCoA carboxylase deficiency restricted to hepatic tissues seems to induce a change towards clinical normalisation and a milder biochemical phenotype. Liver transplanted PA patients still require slight protein restriction and carnitine treatment. We consider that at the moment OLT should only be performed in severe forms of PA, mostly characterised by frequent and unexpected episodes of metabolic decompensation despite good dietary therapy. However, a strict appreciation of these criteria is difficult. A more generalised indication for OLT in PA will require more information about the long-term outcome of transplanted patients. We should also await other alternatives like auxiliary partial OLT from living donors or transplantation of isolated allogenic hepatocytes, genetically modified or not.

AB - Despite the improvement in dietary therapy during the past 20 years, the overall outcome of severe forms of propionic acidaemia (PA) remains often disappointing. Good results can be obtained at a very high price in terms of medical attention, family burden and high cost. In most early onset forms of PA, the intake of natural protein must be rigidly restricted to 8-12 g/day for the first 3 years of life, and then slowly increased to 15-20 g/day by the age of 6-8 years. Supplementation with a precursor-free aminoacid mixture to provide 1.5 g/kg protein per day is generally recommended, although remains controversial. From the age of 1 year onward, these children are often severely anorectic and most of the diet must be delivered by nocturnal gastric drip feeding or gastrostomy. Metronidazole is very effective in reducing the excretion of propionate metabolites derived from the gut. L- carnitine (50 to 100 mg/kg) is systematically given to promote propionylcarnitine synthesis and excretion. We report here a retrospective study of 33 patients with PA diagnosed during the last 20 years in our hospital. Of them, 2 have been liver transplanted. In these two patients who presented frequent severe and unexpected metabolic decompensations despite good compliance with the dietary therapy, orthotopic liver transplantation (OLT) was done at 7 and 9 years respectively. One child died 15 months after transplantation due to a severe lymphoproliferative disorder; the other child now aged 13.5 years is doing well. Despite a persistent methylcitrate excretion, she is under normal moderate daily protein intake (40-50 g/day) and still on carnitine supplementation. Interestingly, another patient who filled the criteria for OLT (very frequent and severe decompensations leading to frequent admissions to the intensive care unit despite excellent dietary management) was also placed on the list for OLT. From the time he was registered onward, he experienced no further episodes of metabolic decompensation, there was almost no interruption in his daily intake and he gained height and weight and developed well. He was finally removed from the list and is still doing very well 2 years thereafter. Correction of propionylCoA carboxylase deficiency restricted to hepatic tissues seems to induce a change towards clinical normalisation and a milder biochemical phenotype. Liver transplanted PA patients still require slight protein restriction and carnitine treatment. We consider that at the moment OLT should only be performed in severe forms of PA, mostly characterised by frequent and unexpected episodes of metabolic decompensation despite good dietary therapy. However, a strict appreciation of these criteria is difficult. A more generalised indication for OLT in PA will require more information about the long-term outcome of transplanted patients. We should also await other alternatives like auxiliary partial OLT from living donors or transplantation of isolated allogenic hepatocytes, genetically modified or not.

KW - Liver transplantation

KW - Management of inborn errors of metabolism

KW - Propionic acidaemia

KW - PropionylCoA carboxylase

UR - http://www.scopus.com/inward/record.url?scp=0032747744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032747744&partnerID=8YFLogxK

M3 - Article

VL - 158

JO - European Journal of Pediatrics, Supplement

JF - European Journal of Pediatrics, Supplement

SN - 0943-9676

IS - 2

ER -